ZA806017B - Morpholine derivatives - Google Patents

Morpholine derivatives

Info

Publication number
ZA806017B
ZA806017B ZA00806017A ZA806017A ZA806017B ZA 806017 B ZA806017 B ZA 806017B ZA 00806017 A ZA00806017 A ZA 00806017A ZA 806017 A ZA806017 A ZA 806017A ZA 806017 B ZA806017 B ZA 806017B
Authority
ZA
South Africa
Prior art keywords
lower alkyl
alkyl
hydrogen
morpholine derivatives
represents hydrogen
Prior art date
Application number
ZA00806017A
Other languages
English (en)
Inventor
A White
E Edington
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of ZA806017B publication Critical patent/ZA806017B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Lubricants (AREA)
  • Signal Processing For Digital Recording And Reproducing (AREA)
ZA00806017A 1979-10-20 1980-09-29 Morpholine derivatives ZA806017B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7936502 1979-10-20

Publications (1)

Publication Number Publication Date
ZA806017B true ZA806017B (en) 1982-04-28

Family

ID=10508675

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00806017A ZA806017B (en) 1979-10-20 1980-09-29 Morpholine derivatives

Country Status (17)

Country Link
US (1) US4360519A (ko)
EP (1) EP0027695B1 (ko)
JP (1) JPS5665880A (ko)
KR (2) KR840002427B1 (ko)
AT (1) ATE4980T1 (ko)
AU (1) AU531586B2 (ko)
CA (1) CA1126731A (ko)
DE (1) DE3065304D1 (ko)
DK (1) DK151800C (ko)
ES (1) ES8107201A1 (ko)
FI (1) FI803277L (ko)
GB (1) GB2061272B (ko)
GR (1) GR70235B (ko)
IE (1) IE50355B1 (ko)
MY (1) MY8500468A (ko)
PT (1) PT71940B (ko)
ZA (1) ZA806017B (ko)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2125793B (en) * 1982-08-19 1985-10-02 Wyeth John & Brother Ltd Morpholine derivatives
GB8305638D0 (en) * 1983-03-01 1983-03-30 Wyeth John & Brother Ltd Morpholine derivatives
FR2553412B1 (fr) * 1983-10-17 1986-03-21 Lafon Labor Derives de 4-alkyl-2-methyl-2-phenyl-morpholine, procede de preparation et utilisation en therapeutique
GB8418657D0 (en) * 1984-07-21 1984-08-22 Beecham Group Plc Compounds
FR2581383A1 (fr) * 1985-05-03 1986-11-07 Cerm Cent Europ Rech Mauvernay 2-alkyl-2-aryl morpholines substituees, leur preparation et les compositions pharmaceutiques les contenant
DE3621775A1 (de) * 1986-03-13 1988-01-07 Thomae Gmbh Dr K Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
GB9108629D0 (en) * 1991-04-23 1991-06-12 Wellcome Found Heterocyclic pharmaceutical compounds,preparation and use
US5637699A (en) * 1992-06-29 1997-06-10 Merck & Co., Inc. Process for preparing morpholine tachykinin receptor antagonists
US6048859A (en) 1992-06-29 2000-04-11 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
US5719147A (en) * 1992-06-29 1998-02-17 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
IL112778A0 (en) * 1994-03-04 1995-05-26 Merck & Co Inc Substituted heterocycles, their preparation and pharmaceutical compositions containing them
KR20050088194A (ko) * 2002-12-19 2005-09-02 머크 앤드 캄파니 인코포레이티드 치환된 아미드
HUE028976T2 (en) 2003-06-17 2017-02-28 Arena Pharm Inc 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride
JP5199997B2 (ja) 2006-04-03 2013-05-15 アリーナ ファーマシューティカルズ， インコーポレイテッド ８−クロロ−１−メチル−２，３，４，５−テトラヒドロ−１ｈ−３−ベンズアゼピンおよびこれに関連する中間体を調製するためのプロセス
SG177128A1 (en) 2006-12-05 2012-01-30 Arena Pharm Inc Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
US8822727B2 (en) 2008-03-04 2014-09-02 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
EP2443080A2 (en) 2009-06-18 2012-04-25 Arena Pharmaceuticals, Inc. Process for the preparation of 5-ht2c receptor agonists
ES2546492T3 (es) 2010-05-21 2015-09-24 Research Triangle Institute Derivados de 1-fenilmorfolina como análogos de hidroxibupropion para tratar drogodependencia
ES2687095T3 (es) 2010-05-21 2018-10-23 Research Triangle Institute Fenilimorfolinas y análogos de las mismas
KR20130112848A (ko) 2010-06-02 2013-10-14 아레나 파마슈티칼스, 인크. 5-ｈｔ2ｃ 수용체 아고니스트의 제조 방법
CN103347523A (zh) 2010-09-01 2013-10-09 艾尼纳制药公司 向具有肾损伤的个体给药氯卡色林
CA2808904A1 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Non-hygroscopic salts of 5-ht2c agonists
EP2611782A1 (en) 2010-09-01 2013-07-10 Arena Pharmaceuticals, Inc. Salts of lorcaserin with optically active acids
EP3485878A1 (en) 2010-09-01 2019-05-22 Arena Pharmaceuticals, Inc. Modified-release dosage forms of 5-ht2c agonists useful for weight management
MY181736A (en) 2012-10-09 2021-01-05 Arena Pharm Inc Method of weight management

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2835669A (en) * 1958-05-20 Process for the production of substi-
US2997469A (en) * 1961-08-22 Preparation of substituted
US3112311A (en) * 1957-04-05 1963-11-26 Geigy Chem Corp 2-phenyl-5, 6-dimethyl-morpholines and 2-phenyl-5, 6-tetramethylene-morpholines
US3296076A (en) * 1962-06-11 1967-01-03 Boehringer Sohn Ingelheim Pilomotor shaving compositions and method of using same
GB1336732A (en) * 1970-10-28 1973-11-07 Istituto Gentili Spa Pisa Diethanolamine derivatives
GB1452701A (en) * 1974-05-07 1976-10-13 Ici Ltd Morpholine derivatives

Also Published As

Publication number Publication date
FI803277L (fi) 1981-04-21
ATE4980T1 (de) 1983-10-15
KR840002427B1 (ko) 1984-12-27
DK151800B (da) 1988-01-04
GB2061272B (en) 1983-08-10
ES496074A0 (es) 1981-10-01
KR840002428B1 (ko) 1984-12-27
GB2061272A (en) 1981-05-13
JPS5665880A (en) 1981-06-03
EP0027695A1 (en) 1981-04-29
IE801995L (en) 1981-04-20
PT71940B (pt) 1981-08-31
MY8500468A (en) 1985-12-31
DK441080A (da) 1981-04-21
PT71940A (en) 1980-11-01
DE3065304D1 (en) 1983-11-17
KR830004277A (ko) 1983-07-09
AU6292280A (en) 1981-04-30
EP0027695B1 (en) 1983-10-12
GR70235B (ko) 1982-09-01
CA1126731A (en) 1982-06-29
US4360519A (en) 1982-11-23
DK151800C (da) 1988-06-06
ES8107201A1 (es) 1981-10-01
IE50355B1 (en) 1986-04-02
AU531586B2 (en) 1983-09-01

Similar Documents

Publication Publication Date Title
GB2061272B (en) Morpholine derivatives
ES485163A1 (es) Procedimiento de preparacion de un nuevo derivado 5h-2,3- benzodiazepinos o de una sal de adicion acida
ES468119A1 (es) Un procedimiento para la preparacion de triazinas
ES8604128A1 (es) Un procedimiento para la preparacion de nuevos derivados de bencenosulfonamida
ES465384A1 (es) Procedimiento para la obtencion de ciclopentan-1-aminas
ES8306142A1 (es) "procedimiento para la preparacion de nuevas n-(4-indolil-piperidino-alcohil)-bencimidazolonas sustituidas".
SE8100403L (sv) Cyklohexen-derivat
GB2108495B (en) Triazoloquinazolone derivatives
ES455741A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1,3-bencenodimetanol.
ES8401456A1 (es) Procedimiento para la preparacion de 2-aminometilfenoles.
FI871253A (fi) 1-/3-(2-dialkylaminoetoxi)-2 -tienyl/-3-fenyl-1-propanoner och deras syraadditionssalter, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska sammansaettningar.
ES462838A1 (es) Procedimiento para la preparacion de compuestos tetracicli- cos biologicamente activos.
JPS5538397A (en) Diuretic drug
ES8103047A1 (es) Procedimiento de preparacion de derivados aminoisoquinolinosasi como de sus sales de adicion acidas, farmaceuticamente aceptables y de sus derivados amonicos cuaternarios
ES8302734A1 (es) Procedimiento para preparar 5'-n-(aminoalquil)-amino-5'-deo-xiadenosina
NO833978L (no) Fremgangsmaate for fremstilling av terapeutisk aktive semikarbazid-derivater
GB2007655A (en) Aryl ethers of N-alkyl- piperidines and acid addition salts thereof